Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cel Sci Corp (CVM)  
$0.25 0.00 (-1.05%) as of 4:30 Thu 4/17


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 38,620,000
Market Cap: 9.84(M)
Last Volume: 2,036,333 Avg Vol: 2,019,286
52 Week Range: $0.1913 - $1.72
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CEL-SCI is a clinical-stage biotechnology company focused on research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. Co. is focused on the development of the following product candidates and technologies: Multikine® (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the potential treatment of certain head and neck cancers; and Ligand Epitope Antigen Presentation System technology, with CEL-4000 as a product candidate under development for the potential treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 58,000 58,000
Total Buy Value $0 $0 $80,620 $80,620
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 3 3
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-01-16 2024-10-15 2024-04-16 2023-04-17

   
Records found: 219
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kersten Geert R Chief Executive Officer   •       •      –    2025-03-31 4 A $0.23 $5,250 D/D 22,786 1,240,378     -
   Prichep Patricia B Chief Financial Officer   •       –      –    2025-03-31 4 A $0.23 $3,556 D/D 15,432 266,230     -
   Talor Eyal Chief Scientific Officer   •       –      –    2025-03-31 4 A $0.23 $2,400 D/D 10,416 135,013     -
   Prichep Patricia B Chief Financial & Operations   •       –      –    2024-12-31 4 A $0.40 $4,291 D/D 10,727 250,798     -
   Talor Eyal Chief Scientific Officer   •       –      –    2024-12-31 4 A $0.40 $2,400 D/D 6,001 124,597     -
   Kersten Geert R CEO   •       •      –    2024-12-31 4 A $0.40 $5,176 D/D 12,940 1,217,592     -
   Prichep Patricia B Sr. VP of Operations   •       –      –    2024-09-30 4 A $1.06 $4,290 D/D 4,047 240,071     -
   Kersten Geert R Chief Executive Officer   •       •      –    2024-09-30 4 A $1.06 $5,175 D/D 4,882 1,204,652     -
   Talor Eyal Chief Scientific Officer   •       –      –    2024-09-30 4 A $1.06 $2,400 D/D 2,264 118,596     -
   Kersten Geert R Chief Executive Officer   •       •      –    2024-06-28 4 A $1.16 $5,175 D/D 4,461 1,199,770     -
   Talor Eyal Chief Scientific Officer   •       –      –    2024-06-28 4 A $1.16 $2,399 D/D 2,068 116,332     -
   Prichep Patricia B Senior Vice President   •       –      –    2024-06-28 4 A $1.16 $4,290 D/D 3,698 236,024     -
   Watson Robert Eugene Director   –       •      –    2024-05-08 4 B $1.39 $27,800 D/D 20,000 24,431 2.39 -19%     
   Kersten Geert R Chief Executive Officer   •       •      –    2024-05-08 4 B $1.39 $41,700 D/D 30,000 1,195,309 2.81 -19%     
   Prichep Patricia B Senior Vice President   •       –      –    2024-05-08 4 B $1.39 $11,120 D/D 8,000 232,326 2.74 -19%     
   Prichep Patricia B Senior Vice President   •       –      –    2024-03-29 4 A $1.91 $4,290 D/D 2,246 224,326     -
   Talor Eyal Chief Scientific Officer   •       –      –    2024-03-29 4 A $1.91 $2,399 D/D 1,256 114,264     -
   Kersten Geert R Chief Executive Officer   •       •      –    2024-03-29 4 A $1.91 $5,174 D/D 2,709 1,165,309     -
   Talor Eyal Chief Scientific Officer   •       –      –    2023-12-29 4 A $2.72 $2,399 D/D 882 113,008     -
   Kersten Geert R Chief Executive Officer   •       •      –    2023-12-29 4 A $2.72 $4,948 D/D 1,819 1,162,600     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-12-29 4 A $2.72 $4,289 D/D 1,577 222,080     -
   Talor Eyal Chief Scientific Officer   •       –      –    2023-09-29 4 A $1.25 $2,400 D/D 1,920 112,126     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-09-29 4 A $1.25 $4,290 D/D 3,432 220,503     -
   Kersten Geert R Chief Executive Officer   •       •      –    2023-09-29 4 A $1.25 $4,950 D/D 3,960 1,160,781     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-06-30 4 A $2.41 $4,290 D/D 1,780 217,071     -
  219 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us